Atea Pharmaceuticals, Inc. (AVIR) Revenue 2021–2022
Atea Pharmaceuticals, Inc. (AVIR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$351.4MFY2022 · since FY2021: $48.6M → $351.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $351.4M | +622.5% |
| FY2021 | $48.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AVIR financial trends
AVIR Net incomeAVIR Net marginAVIR Gross profitAVIR Gross marginAVIR Operating incomeAVIR Operating marginAVIR Operating cash flowAVIR Free cash flowAVIR Capital expendituresAVIR Return on equityAVIR Stock buybacksAVIR Dividends paidAVIR Total assetsAVIR Total liabilitiesAVIR Shareholders’ equityAVIR overview →